Changing epidemiology of hepatitis A infection in Izmir, Turkey

Vaccine

Volumn 29, Issue 37, 2011, Pages 6259-6261

  Kurugol, Zafer ^a   Aslan, Asli ^a   Turkoglu, Ebru ^a   Koturoglu, Guldane ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Hepatitis A; Prevalence; Vaccination

Indexed keywords

HEPATITIS A ANTIBODY; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; ARTICLE; BLOOD ANALYSIS; CHILD; CHILDHOOD; CONTROLLED STUDY; FAMILY SIZE; FEMALE; GENDER; GROUPS BY AGE; HEPATITIS A; HUMAN; INCOME; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RURAL AREA; SCHOOL CHILD; SEROPREVALENCE; TURKEY (REPUBLIC); URBAN AREA;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS A; HEPATITIS A ANTIBODIES; HEPATITIS A ANTIGENS; HEPATITIS A VIRUS; HUMANS; INFANT; MALE; MIDDLE AGED; QUESTIONNAIRES; SEROEPIDEMIOLOGIC STUDIES; TURKEY;

EID: 80051569834     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.06.069     Document Type: Article

References (22)

1. Shapiro C.N. Hepatitis A virus. Principles and practice of pediatric infectious diseases 2003, Churchill Livingstone Inc., London. 2nd ed. S.L. Long, L.K. Pickering, C.G. Prober (Eds.).
2. Barzaga B.N. Hepatitis A shifting epidemiology in South-east Asia and China. Vaccine 2000, 18:61-64.
3. Cianciara J. Hepatitis A shifting epidemiology in Poland and Eastern Europe. Vaccine 2000, 18:68-70.
4. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine 2000, 18:57-60.
5. Tufenkeji H. Hepatitis A shifting epidemiology in the Middles East and Africa. Vaccine 2000, 18:65-67.
6. Green M.S., Aharonowitz G., Shohat T., Levine R., Anis E., Slater P.E. The changing epidemiology of viral hepatitis A in Israel. Isr Med Assoc J 2001, 3:347-351.
7. Rothenberg R.B., Labanov A., Singh K.B., Stroh G. Observations on the application of EPI cluster survey methods for estimating disease incidence. Bull World Health Organ 1985, 63:93-99.
8. Henderson R.H., Sundaresan T. Cluster sampling to assess immunization coverage: a review of experience with a implified sampling method. Bull World Health Organ 1982, 60:253-260.
9. Kanra G., Tezcan S., Badur S. Hepatitis A seroprevalence in a random sample of the Turkish population by simultaneous EPI cluster and comparison with surveys in Turkey. Turk J Pediatr 2002, 44:204-210. Turkish National Study Team.
10. Ceyhan M., Yildirim I., Kurt N., Uysal G., Dikici B., Ecevit C., et al. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. J Viral Hepat 2008, 15:69-72.
11. Geyman A., Baz I. Monitoring urban growth and detecting land cover changes on the Istanbul metropolitan area. Environ Monit Assess 2008, 136:449-459.
12. FitzSimons D., Hendrickx G., Vorsters A., Van Damme P. Hepatitis A and E: update on prevention and epidemiology. Vaccine 2010, 28:583-588.
13. Wasley A., Samandari T., Bell B.P. Incidence of hepatitis A in the United Stats in the era of vaccination. JAMA 2005, 294:194-201.
14. Innis B.L., Snitbhan R., Kunasol P., Laorakpongse T., Poopatanakool W., Kozik C.A., et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994, 271:1328-1334.
15. WHO Hepatitis A vaccines position paper. Wkly Epidemiol Rec 2000, 75:38-44.
16. Dagan R., Leventhal A., Anis E., Slater P., Ashur Y., Shouval D. Incidence of hepatitis A in Israel following universal immunization of toddlers. JAMA 2005, 294:202-210.
17. Salleras L., Bruguera M., Buti M., Domingez A. Prospects for vaccination against hepatitis A and B in Catalonia (Spain). Vaccine 2000, 18:80-82.
18. Germinario C., Lopalco P.L., Chicanna M., Da Villa G. From hepatitis B to hepatitis A and B prevention: the Puglia (Italy) experience. Vaccine 2000, 18:83-85.
19. Al Faleh F., Al Shehri S., Al Ansari S., Al Jeffri M., Al Mazrou Y., Shaffi A., et al. Changing patterns of hepatitis A prevalence within the Saudi population over the last 18 years. World J Gastroenterol 2008, 14:7371-7375.
20. Kyrka A., Tragiannidis A., Cassimos D., Pantelaki K., Tzoufi M., Mavrokosta M., et al. Seroepidemiology of hepatitis A among Greek children indicates that the virus is still prevalent: implications for universal vaccination. J Med Virol 2009, 81:582-587.
21. Vacchino M.N. Incidence of hepatitis A in Argentina after vaccination. J Viral Hepat 2008, 15:47-50.
22. Zhuang G.H., Pan X.J., Wang X.L. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China. Vaccine 2008, 26:4608-4616.